Correction of Stock Option Grant: Exercise Price Lowered and Shares Increased


  • Correction filing: Amendment to stock option grant report (original filed 2019.06.14, correction 2026.05.14)
  • Grantees: decreased from 5 to 3
  • Shares granted: increased from 108,000 to 202,000 (+87%)
  • Exercise price: significantly lowered from 40,600 won to 11,600 won (adjusted due to capital increase and stock dividend)
  • Total outstanding options after this grant: increased from 1,941,396 to 4,092,568 shares
  • Fair value: slightly decreased from 35,964 won to 34,972 won
  • Exercise period: 2021.06.15 ~ 2028.06.14
  • Valuation model: Binomial model, key assumptions: risk-free rate 1.59%, expected volatility 77.84%

KOSDAQ Filing Information


  • Filing: [Correction of Description] Report on Grant of Stock Options
  • Company: Genome & (314130)
  • Submission: Genome & Company
  • Receipt: 05-14-2026